カテゴリー： 世界, 医療/バイオ, QYResearch

ニューロテンシンの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Neurotensin Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10427）・商品コード：QY22JLX10427
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、ニューロテンシンのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にニューロテンシンの世界市場のxxx％を占める「人間」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ニューロテンシンの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのニューロテンシン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ニューロテンシンのグローバル主要企業には、Peptide Institute、Genscript、Bio - Techne、MedChemExpress、PerkinElmer、APExBIO、Eurogentecなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ニューロテンシン市場は、種類と用途によって区分されます。世界のニューロテンシン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
人間、ウシ、イヌ、ネズミ

【用途別セグメント】
科学研究、医療、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ニューロテンシン製品概要
- 種類別市場（人間、ウシ、イヌ、ネズミ）
- 用途別市場（科学研究、医療、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のニューロテンシン販売量予測2017-2028
- 世界のニューロテンシン売上予測2017-2028
- ニューロテンシンの地域別販売量
- ニューロテンシンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ニューロテンシン販売量
- 主要メーカー別ニューロテンシン売上
- 主要メーカー別ニューロテンシン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（人間、ウシ、イヌ、ネズミ）
- ニューロテンシンの種類別販売量
- ニューロテンシンの種類別売上
- ニューロテンシンの種類別価格
・用途別市場規模（科学研究、医療、その他）
- ニューロテンシンの用途別販売量
- ニューロテンシンの用途別売上
- ニューロテンシンの用途別価格
・北米市場
- 北米のニューロテンシン市場規模（種類別、用途別）
- 主要国別のニューロテンシン市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのニューロテンシン市場規模（種類別、用途別）
- 主要国別のニューロテンシン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のニューロテンシン市場規模（種類別、用途別）
- 主要国別のニューロテンシン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のニューロテンシン市場規模（種類別、用途別）
- 主要国別のニューロテンシン市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのニューロテンシン市場規模（種類別、用途別）
- 主要国別のニューロテンシン市場規模（トルコ、サウジアラビア）
・企業情報
Peptide Institute、Genscript、Bio - Techne、MedChemExpress、PerkinElmer、APExBIO、Eurogentec
・産業チェーン及び販売チャネル分析
- ニューロテンシンの産業チェーン分析
- ニューロテンシンの原材料
- ニューロテンシンの生産プロセス
- ニューロテンシンの販売及びマーケティング
- ニューロテンシンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ニューロテンシンの産業動向
- ニューロテンシンのマーケットドライバー
- ニューロテンシンの課題
- ニューロテンシンの阻害要因
・主な調査結果

Market Analysis and Insights: Global Neurotensin Market
Due to the COVID-19 pandemic, the global Neurotensin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Human accounting for % of the Neurotensin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Scientific Research segment is altered to an % CAGR throughout this forecast period.
China Neurotensin market size is valued at US$ million in 2021, while the US and Europe Neurotensin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Neurotensin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Neurotensin include Peptide Institute, Genscript, Bio – Techne, MedChemExpress, PerkinElmer, APExBIO and Eurogentec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Neurotensin Scope and Segment
Neurotensin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Neurotensin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Human
Bovine
Canine
Mouse
Segment by Application
Scientific Research
Medical
Others
By Company
Peptide Institute
Genscript
Bio – Techne
MedChemExpress
PerkinElmer
APExBIO
Eurogentec
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Neurotensin Product Introduction
1.2 Market by Type
1.2.1 Global Neurotensin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Human
1.2.3 Bovine
1.2.4 Canine
1.2.5 Mouse
1.3 Market by Application
1.3.1 Global Neurotensin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neurotensin Sales Estimates and Forecasts 2017-2028
2.2 Global Neurotensin Revenue Estimates and Forecasts 2017-2028
2.3 Global Neurotensin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Neurotensin Sales by Region
2.4.1 Global Neurotensin Sales by Region (2017-2022)
2.4.2 Global Sales Neurotensin by Region (2023-2028)
2.5 Global Neurotensin Revenue by Region
2.5.1 Global Neurotensin Revenue by Region (2017-2022)
2.5.2 Global Neurotensin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neurotensin Sales by Manufacturers
3.1.1 Global Top Neurotensin Manufacturers by Sales (2017-2022)
3.1.2 Global Neurotensin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurotensin in 2021
3.2 Global Neurotensin Revenue by Manufacturers
3.2.1 Global Neurotensin Revenue by Manufacturers (2017-2022)
3.2.2 Global Neurotensin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Neurotensin Revenue in 2021
3.3 Global Neurotensin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neurotensin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neurotensin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neurotensin Sales by Type
4.1.1 Global Neurotensin Historical Sales by Type (2017-2022)
4.1.2 Global Neurotensin Forecasted Sales by Type (2023-2028)
4.1.3 Global Neurotensin Sales Market Share by Type (2017-2028)
4.2 Global Neurotensin Revenue by Type
4.2.1 Global Neurotensin Historical Revenue by Type (2017-2022)
4.2.2 Global Neurotensin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Neurotensin Revenue Market Share by Type (2017-2028)
4.3 Global Neurotensin Price by Type
4.3.1 Global Neurotensin Price by Type (2017-2022)
4.3.2 Global Neurotensin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Neurotensin Sales by Application
5.1.1 Global Neurotensin Historical Sales by Application (2017-2022)
5.1.2 Global Neurotensin Forecasted Sales by Application (2023-2028)
5.1.3 Global Neurotensin Sales Market Share by Application (2017-2028)
5.2 Global Neurotensin Revenue by Application
5.2.1 Global Neurotensin Historical Revenue by Application (2017-2022)
5.2.2 Global Neurotensin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Neurotensin Revenue Market Share by Application (2017-2028)
5.3 Global Neurotensin Price by Application
5.3.1 Global Neurotensin Price by Application (2017-2022)
5.3.2 Global Neurotensin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Neurotensin Market Size by Type
6.1.1 North America Neurotensin Sales by Type (2017-2028)
6.1.2 North America Neurotensin Revenue by Type (2017-2028)
6.2 North America Neurotensin Market Size by Application
6.2.1 North America Neurotensin Sales by Application (2017-2028)
6.2.2 North America Neurotensin Revenue by Application (2017-2028)
6.3 North America Neurotensin Market Size by Country
6.3.1 North America Neurotensin Sales by Country (2017-2028)
6.3.2 North America Neurotensin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Neurotensin Market Size by Type
7.1.1 Europe Neurotensin Sales by Type (2017-2028)
7.1.2 Europe Neurotensin Revenue by Type (2017-2028)
7.2 Europe Neurotensin Market Size by Application
7.2.1 Europe Neurotensin Sales by Application (2017-2028)
7.2.2 Europe Neurotensin Revenue by Application (2017-2028)
7.3 Europe Neurotensin Market Size by Country
7.3.1 Europe Neurotensin Sales by Country (2017-2028)
7.3.2 Europe Neurotensin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neurotensin Market Size by Type
8.1.1 Asia Pacific Neurotensin Sales by Type (2017-2028)
8.1.2 Asia Pacific Neurotensin Revenue by Type (2017-2028)
8.2 Asia Pacific Neurotensin Market Size by Application
8.2.1 Asia Pacific Neurotensin Sales by Application (2017-2028)
8.2.2 Asia Pacific Neurotensin Revenue by Application (2017-2028)
8.3 Asia Pacific Neurotensin Market Size by Region
8.3.1 Asia Pacific Neurotensin Sales by Region (2017-2028)
8.3.2 Asia Pacific Neurotensin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Neurotensin Market Size by Type
9.1.1 Latin America Neurotensin Sales by Type (2017-2028)
9.1.2 Latin America Neurotensin Revenue by Type (2017-2028)
9.2 Latin America Neurotensin Market Size by Application
9.2.1 Latin America Neurotensin Sales by Application (2017-2028)
9.2.2 Latin America Neurotensin Revenue by Application (2017-2028)
9.3 Latin America Neurotensin Market Size by Country
9.3.1 Latin America Neurotensin Sales by Country (2017-2028)
9.3.2 Latin America Neurotensin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neurotensin Market Size by Type
10.1.1 Middle East and Africa Neurotensin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Neurotensin Revenue by Type (2017-2028)
10.2 Middle East and Africa Neurotensin Market Size by Application
10.2.1 Middle East and Africa Neurotensin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Neurotensin Revenue by Application (2017-2028)
10.3 Middle East and Africa Neurotensin Market Size by Country
10.3.1 Middle East and Africa Neurotensin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Neurotensin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Peptide Institute
11.1.1 Peptide Institute Corporation Information
11.1.2 Peptide Institute Overview
11.1.3 Peptide Institute Neurotensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Peptide Institute Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Peptide Institute Recent Developments
11.2 Genscript
11.2.1 Genscript Corporation Information
11.2.2 Genscript Overview
11.2.3 Genscript Neurotensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Genscript Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Genscript Recent Developments
11.3 Bio – Techne
11.3.1 Bio – Techne Corporation Information
11.3.2 Bio – Techne Overview
11.3.3 Bio – Techne Neurotensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bio – Techne Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bio – Techne Recent Developments
11.4 MedChemExpress
11.4.1 MedChemExpress Corporation Information
11.4.2 MedChemExpress Overview
11.4.3 MedChemExpress Neurotensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MedChemExpress Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MedChemExpress Recent Developments
11.5 PerkinElmer
11.5.1 PerkinElmer Corporation Information
11.5.2 PerkinElmer Overview
11.5.3 PerkinElmer Neurotensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 PerkinElmer Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 PerkinElmer Recent Developments
11.6 APExBIO
11.6.1 APExBIO Corporation Information
11.6.2 APExBIO Overview
11.6.3 APExBIO Neurotensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 APExBIO Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 APExBIO Recent Developments
11.7 Eurogentec
11.7.1 Eurogentec Corporation Information
11.7.2 Eurogentec Overview
11.7.3 Eurogentec Neurotensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Eurogentec Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eurogentec Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neurotensin Industry Chain Analysis
12.2 Neurotensin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurotensin Production Mode & Process
12.4 Neurotensin Sales and Marketing
12.4.1 Neurotensin Sales Channels
12.4.2 Neurotensin Distributors
12.5 Neurotensin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neurotensin Industry Trends
13.2 Neurotensin Market Drivers
13.3 Neurotensin Market Challenges
13.4 Neurotensin Market Restraints
14 Key Findings in The Global Neurotensin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Neurotensin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Human
Table 3. Major Manufacturers of Bovine
Table 4. Major Manufacturers of Canine
Table 5. Major Manufacturers of Mouse
Table 6. Global Neurotensin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Neurotensin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Neurotensin Sales by Region (2017-2022) & (K Units)
Table 9. Global Neurotensin Sales Market Share by Region (2017-2022)
Table 10. Global Neurotensin Sales by Region (2023-2028) & (K Units)
Table 11. Global Neurotensin Sales Market Share by Region (2023-2028)
Table 12. Global Neurotensin Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Neurotensin Revenue Market Share by Region (2017-2022)
Table 14. Global Neurotensin Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Neurotensin Revenue Market Share by Region (2023-2028)
Table 16. Global Neurotensin Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Neurotensin Sales Share by Manufacturers (2017-2022)
Table 18. Global Neurotensin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Neurotensin Revenue Share by Manufacturers (2017-2022)
Table 20. Neurotensin Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Neurotensin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Neurotensin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurotensin as of 2021)
Table 23. Neurotensin Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Neurotensin Product Offered
Table 25. Date of Manufacturers Enter into Neurotensin Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neurotensin Sales by Type (2017-2022) & (K Units)
Table 28. Global Neurotensin Sales by Type (2023-2028) & (K Units)
Table 29. Global Neurotensin Sales Share by Type (2017-2022)
Table 30. Global Neurotensin Sales Share by Type (2023-2028)
Table 31. Global Neurotensin Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Neurotensin Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Neurotensin Revenue Share by Type (2017-2022)
Table 34. Global Neurotensin Revenue Share by Type (2023-2028)
Table 35. Neurotensin Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Neurotensin Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Neurotensin Sales by Application (2017-2022) & (K Units)
Table 38. Global Neurotensin Sales by Application (2023-2028) & (K Units)
Table 39. Global Neurotensin Sales Share by Application (2017-2022)
Table 40. Global Neurotensin Sales Share by Application (2023-2028)
Table 41. Global Neurotensin Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Neurotensin Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Neurotensin Revenue Share by Application (2017-2022)
Table 44. Global Neurotensin Revenue Share by Application (2023-2028)
Table 45. Neurotensin Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Neurotensin Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Neurotensin Sales by Type (2017-2022) & (K Units)
Table 48. North America Neurotensin Sales by Type (2023-2028) & (K Units)
Table 49. North America Neurotensin Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Neurotensin Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Neurotensin Sales by Application (2017-2022) & (K Units)
Table 52. North America Neurotensin Sales by Application (2023-2028) & (K Units)
Table 53. North America Neurotensin Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Neurotensin Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Neurotensin Sales by Country (2017-2022) & (K Units)
Table 56. North America Neurotensin Sales by Country (2023-2028) & (K Units)
Table 57. North America Neurotensin Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Neurotensin Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Neurotensin Sales by Type (2017-2022) & (K Units)
Table 60. Europe Neurotensin Sales by Type (2023-2028) & (K Units)
Table 61. Europe Neurotensin Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Neurotensin Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Neurotensin Sales by Application (2017-2022) & (K Units)
Table 64. Europe Neurotensin Sales by Application (2023-2028) & (K Units)
Table 65. Europe Neurotensin Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Neurotensin Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Neurotensin Sales by Country (2017-2022) & (K Units)
Table 68. Europe Neurotensin Sales by Country (2023-2028) & (K Units)
Table 69. Europe Neurotensin Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Neurotensin Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Neurotensin Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Neurotensin Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Neurotensin Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Neurotensin Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Neurotensin Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Neurotensin Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Neurotensin Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Neurotensin Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Neurotensin Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Neurotensin Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Neurotensin Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Neurotensin Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Neurotensin Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Neurotensin Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Neurotensin Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Neurotensin Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Neurotensin Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Neurotensin Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Neurotensin Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Neurotensin Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Neurotensin Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Neurotensin Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Neurotensin Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Neurotensin Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Neurotensin Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Neurotensin Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Neurotensin Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Neurotensin Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Neurotensin Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Neurotensin Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Neurotensin Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Neurotensin Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Neurotensin Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Neurotensin Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Neurotensin Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Neurotensin Revenue by Country (2023-2028) & (US$ Million)
Table 107. Peptide Institute Corporation Information
Table 108. Peptide Institute Description and Major Businesses
Table 109. Peptide Institute Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Peptide Institute Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Peptide Institute Recent Developments
Table 112. Genscript Corporation Information
Table 113. Genscript Description and Major Businesses
Table 114. Genscript Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Genscript Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Genscript Recent Developments
Table 117. Bio - Techne Corporation Information
Table 118. Bio - Techne Description and Major Businesses
Table 119. Bio - Techne Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Bio - Techne Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bio - Techne Recent Developments
Table 122. MedChemExpress Corporation Information
Table 123. MedChemExpress Description and Major Businesses
Table 124. MedChemExpress Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. MedChemExpress Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MedChemExpress Recent Developments
Table 127. PerkinElmer Corporation Information
Table 128. PerkinElmer Description and Major Businesses
Table 129. PerkinElmer Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. PerkinElmer Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. PerkinElmer Recent Developments
Table 132. APExBIO Corporation Information
Table 133. APExBIO Description and Major Businesses
Table 134. APExBIO Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. APExBIO Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. APExBIO Recent Developments
Table 137. Eurogentec Corporation Information
Table 138. Eurogentec Description and Major Businesses
Table 139. Eurogentec Neurotensin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Eurogentec Neurotensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Eurogentec Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Neurotensin Distributors List
Table 145. Neurotensin Customers List
Table 146. Neurotensin Market Trends
Table 147. Neurotensin Market Drivers
Table 148. Neurotensin Market Challenges
Table 149. Neurotensin Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurotensin Product Picture
Figure 3. Global Neurotensin Market Share by Type in 2021 & 2028
Figure 3. Human Product Picture
Figure 4. Bovine Product Picture
Figure 5. Canine Product Picture
Figure 6. Mouse Product Picture
Figure 7. Global Neurotensin Market Share by Application in 2021 & 2028
Figure 8. Scientific Research
Figure 9. Medical
Figure 10. Others
Figure 11. Neurotensin Report Years Considered
Figure 12. Global Neurotensin Sales 2017-2028 (K Units)
Figure 13. Global Neurotensin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Neurotensin Revenue 2017-2028 (US$ Million)
Figure 15. Global Neurotensin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Neurotensin Sales Market Share by Region (2017-2022)
Figure 17. Global Neurotensin Sales Market Share by Region (2023-2028)
Figure 18. North America Neurotensin Sales YoY (2017-2028) & (K Units)
Figure 19. North America Neurotensin Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Neurotensin Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Neurotensin Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Neurotensin Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Neurotensin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Neurotensin Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Neurotensin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Neurotensin Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Neurotensin Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Neurotensin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Neurotensin in the World: Market Share by Neurotensin Revenue in 2021
Figure 30. Global Neurotensin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Neurotensin Sales Market Share by Type (2017-2028)
Figure 32. Global Neurotensin Revenue Market Share by Type (2017-2028)
Figure 33. Global Neurotensin Sales Market Share by Application (2017-2028)
Figure 34. Global Neurotensin Revenue Market Share by Application (2017-2028)
Figure 35. North America Neurotensin Sales Market Share by Type (2017-2028)
Figure 36. North America Neurotensin Revenue Market Share by Type (2017-2028)
Figure 37. North America Neurotensin Sales Market Share by Application (2017-2028)
Figure 38. North America Neurotensin Revenue Market Share by Application (2017-2028)
Figure 39. North America Neurotensin Sales Share by Country (2017-2028)
Figure 40. North America Neurotensin Revenue Share by Country (2017-2028)
Figure 41. United States Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Neurotensin Sales Market Share by Type (2017-2028)
Figure 44. Europe Neurotensin Revenue Market Share by Type (2017-2028)
Figure 45. Europe Neurotensin Sales Market Share by Application (2017-2028)
Figure 46. Europe Neurotensin Revenue Market Share by Application (2017-2028)
Figure 47. Europe Neurotensin Sales Share by Country (2017-2028)
Figure 48. Europe Neurotensin Revenue Share by Country (2017-2028)
Figure 49. Germany Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 50. France Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Neurotensin Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Neurotensin Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Neurotensin Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Neurotensin Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Neurotensin Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Neurotensin Revenue Share by Region (2017-2028)
Figure 60. China Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 63. India Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Neurotensin Sales Market Share by Type (2017-2028)
Figure 70. Latin America Neurotensin Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Neurotensin Sales Market Share by Application (2017-2028)
Figure 72. Latin America Neurotensin Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Neurotensin Sales Share by Country (2017-2028)
Figure 74. Latin America Neurotensin Revenue Share by Country (2017-2028)
Figure 75. Mexico Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Neurotensin Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Neurotensin Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Neurotensin Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Neurotensin Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Neurotensin Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Neurotensin Revenue Share by Country (2017-2028)
Figure 84. Turkey Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Neurotensin Revenue (2017-2028) & (US$ Million)
Figure 87. Neurotensin Value Chain
Figure 88. Neurotensin Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed


★調査レポート[ニューロテンシンの世界市場インサイト・予測（～2028年）] (コード：QY22JLX10427)販売に関する免責事項を必ずご確認ください。
★調査レポート[ニューロテンシンの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • アジュバントペプチドの世界市場インサイト・予測（～2028年）
  • 結膜炎治療の世界市場インサイト・予測（～2028年）
  • ダラツムマブ注射の世界市場インサイト・予測（～2028年）
  • デノスマブの世界市場インサイト・予測（～2028年）
  • マイオビューの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆